Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431.

Mast KJ, Taub JW, Alonzo TA, Gamis AS, Mosse CA, Mathew P, Berman JN, Wang YC, Jones HM, Campana D, Coustan-Smith E, Raimondi SC, Hirsch B, Hitzler JK, Head DR.

Arch Pathol Lab Med. 2019 Aug 20. doi: 10.5858/arpa.2018-0526-OA. [Epub ahead of print]

PMID:
31429606
2.

Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum.

Allison SL, Rodebaugh TL, Johnston C, Fagan AM, Morris JC, Head D.

Arch Clin Neuropsychol. 2019 Jun 14. pii: acz019. doi: 10.1093/arclin/acz019. [Epub ahead of print]

PMID:
31197326
3.

A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.

Roe CM, Stout SH, Rajasekar G, Ances BM, Jones JM, Head D, Benzinger TLS, Williams MM, Davis JD, Ott BR, Warren DK, Babulal GM.

J Alzheimers Dis. 2019;68(4):1625-1633. doi: 10.3233/JAD-181242.

PMID:
30958365
4.

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers.

Roe CM, Ances BM, Head D, Babulal GM, Stout SH, Grant EA, Hassenstab J, Xiong C, Holtzman DM, Benzinger TLS, Schindler SE, Fagan AM, Morris JC.

Brain. 2018 Nov 1;141(11):3233-3248. doi: 10.1093/brain/awy244.

PMID:
30304397
5.

Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.

Allison S, Babulal GM, Stout SH, Barco PP, Carr DB, Fagan AM, Morris JC, Roe CM, Head D.

Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):101-106. doi: 10.1097/WAD.0000000000000257.

6.

Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers.

Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM.

Alzheimers Dement. 2018 May;14(5):610-616. doi: 10.1016/j.jalz.2017.11.011. Epub 2018 Jan 10.

7.

Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.

Strickland SA, Shaver AC, Byrne M, Daber RD, Ferrell PB, Head DR, Mohan SR, Mosse CA, Moyo TK, Stricker TP, Vnencak-Jones C, Savona MR, Seegmiller AC.

Leuk Res. 2018 Feb;65:67-73. doi: 10.1016/j.leukres.2017.12.012. Epub 2018 Jan 2.

8.
9.

Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.

Nedelcu E, Desai M, Green J, Bensing KM, Turner A, Head D, Young PP.

Transfusion. 2018 Jan;58(1):176-180. doi: 10.1111/trf.14363. Epub 2017 Oct 11.

PMID:
29023757
10.

Route repetition and route reversal: Effects of age and encoding method.

Allison S, Head D.

Psychol Aging. 2017 May;32(3):220-231. doi: 10.1037/pag0000170.

11.

Validity of Robot-Based Assessments of Upper Extremity Function.

McKenzie A, Dodakian L, See J, Le V, Quinlan EB, Bridgford C, Head D, Han VL, Cramer SC.

Arch Phys Med Rehabil. 2017 Oct;98(10):1969-1976.e2. doi: 10.1016/j.apmr.2017.02.033. Epub 2017 May 5.

12.

Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.

Babulal GM, Stout SH, Head D, Holtzman DM, Fagan AM, Morris JC, Roe CM.

J Alzheimers Dis. 2017;58(3):675-680. doi: 10.3233/JAD-170067.

13.

Preclinical Alzheimer's disease and longitudinal driving decline.

Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, Holtzman DM, Benzinger TLS, Fagan AM, Ott BR, Carr DB, Morris JC.

Alzheimers Dement (N Y). 2017 Jan;3(1):74-82. doi: 10.1016/j.trci.2016.11.006.

14.

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.

Taub JW, Berman JN, Hitzler JK, Sorrell AD, Lacayo NJ, Mast K, Head D, Raimondi S, Hirsch B, Ge Y, Gerbing RB, Wang YC, Alonzo TA, Campana D, Coustan-Smith E, Mathew P, Gamis AS.

Blood. 2017 Jun 22;129(25):3304-3313. doi: 10.1182/blood-2017-01-764324. Epub 2017 Apr 7.

15.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Horsfall R, Johnson RA, Juckett M, Klimek VM, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Shami PJ, Stein BL, Walker AR, Westervelt P, Zeidan A, Shead DA, Smith C.

J Natl Compr Canc Netw. 2017 Jan;15(1):60-87.

PMID:
28040720
16.

The impact of electrode resistance on the biogalvanic characterisation technique.

Chandler JH, Head DA, Hubbard ME, Neville A, Jayne DG, Culmer PR.

Physiol Meas. 2017 Feb;38(2):101-115. doi: 10.1088/1361-6579/38/2/101. Epub 2016 Dec 29.

17.

Latent structure of cognitive performance in the adult children study.

Head D, Allison S, Lucena N, Hassenstab J, Morris JC.

J Clin Exp Neuropsychol. 2017 Sep;39(7):621-635. doi: 10.1080/13803395.2016.1252725. Epub 2016 Nov 20.

18.

Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization.

Seegmiller AC, Kim AS, Mosse CA, Shaver AC, Thompson MA, Li S, Head DR, Zutter MM.

Am J Clin Pathol. 2016 Nov 1;146(5):585-593. doi: 10.1093/ajcp/aqw180.

PMID:
27769956
19.

Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.

Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, Fagan AM, Morris JC, Roe CM.

Am J Geriatr Psychiatry. 2016 Nov;24(11):1095-1104. doi: 10.1016/j.jagp.2016.04.004. Epub 2016 Apr 19.

20.

Biomechanical Analysis of Infectious Biofilms.

Head D.

Adv Exp Med Biol. 2016;915:99-114. doi: 10.1007/978-3-319-32189-9_8. Review.

21.

Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals.

Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, Holtzman DM, Benzinger TL, Fagan AM, Carr DB, Morris JC.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):69-72. doi: 10.1097/WAD.0000000000000154.

22.

Importance of non-affine viscoelastic response in disordered fibre networks.

Rizzi LG, Auer S, Head DA.

Soft Matter. 2016 May 11;12(19):4332-8. doi: 10.1039/c6sm00139d.

23.

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC.

Neurology. 2016 Apr 19;86(16):1499-506. doi: 10.1212/WNL.0000000000002593. Epub 2016 Mar 23.

24.

Spatial Navigation in Preclinical Alzheimer's Disease.

Allison SL, Fagan AM, Morris JC, Head D.

J Alzheimers Dis. 2016 Feb 9;52(1):77-90. doi: 10.3233/JAD-150855.

25.

The mental health of US Black women: the roles of social context and severe intimate partner violence.

Lacey KK, Parnell R, Mouzon DM, Matusko N, Head D, Abelson JM, Jackson JS.

BMJ Open. 2015 Oct 19;5(10):e008415. doi: 10.1136/bmjopen-2015-008415.

26.

Adults Aged 65 and Older Use Potentially Distracting Electronic Devices While Driving.

Vernon EK, Babulal GM, Head D, Carr D, Ghoshal N, Barco PP, Morris JC, Roe CM.

J Am Geriatr Soc. 2015 Jun;63(6):1251-4. doi: 10.1111/jgs.13499. No abstract available.

27.

A Genetic Variant (COMT) Coding Dopaminergic Activity Predicts Personality Traits in Healthy Elderly.

Kotyuk E, Duchek J, Head D, Szekely A, Goate AM, Balota DA.

Pers Individ Dif. 2015 Aug 1;82:61-66.

28.

Ecological approaches to oral biofilms: control without killing.

Marsh PD, Head DA, Devine DA.

Caries Res. 2015;49 Suppl 1:46-54. doi: 10.1159/000377732. Epub 2015 Apr 13. Review.

29.

Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.

Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM.

JAMA Neurol. 2015 Jun;72(6):656-65. doi: 10.1001/jamaneurol.2015.0202.

30.

Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.

Kim A, Fagan AM, Goate AM, Benzinger TL, Morris JC, Head D; Alzheimer’s Disease Neuroimaging Initiative.

Cogn Affect Behav Neurosci. 2015 Sep;15(3):625-43. doi: 10.3758/s13415-015-0343-x.

31.

Universality in the morphology and mechanics of coarsening amyloid fibril networks.

Rizzi LG, Head DA, Auer S.

Phys Rev Lett. 2015 Feb 20;114(7):078102. Epub 2015 Feb 18.

32.

Myelodysplastic syndromes, version 2.2015.

Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Klimek V, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Scott B, Shami PJ, Stein BL, Westervelt P, Wheeler B, Shead DA, Smith C; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Mar;13(3):261-72.

33.

The effects of texting on driving performance in a driving simulator: the influence of driver age.

Rumschlag G, Palumbo T, Martin A, Head D, George R, Commissaris RL.

Accid Anal Prev. 2015 Jan;74:145-9. doi: 10.1016/j.aap.2014.10.009. Epub 2014 Oct 31.

PMID:
25463954
34.

Prospects of oral disease control in the future - an opinion.

Marsh PD, Head DA, Devine DA.

J Oral Microbiol. 2014 Nov 27;6:26176. doi: 10.3402/jom.v6.26176. eCollection 2014.

35.

Non-lethal control of the cariogenic potential of an agent-based model for dental plaque.

Head DA, Marsh PD, Devine DA.

PLoS One. 2014 Aug 21;9(8):e105012. doi: 10.1371/journal.pone.0105012. eCollection 2014.

36.

Prevalence and Contents of Advance Directives in Patients Receiving Home Parenteral Nutrition.

Bui GT, Edakkanambeth Varayil J, Hurt RT, Neutzling KA, Cook KE, Head DL, Mueller PS, Swetz KM.

JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):399-404. doi: 10.1177/0148607114544323. Epub 2014 Aug 5.

PMID:
25096547
37.

Vitamin D deficiency in anesthesia department caregivers at the end of winter.

Skarphedinsdottir SJ, Sigurdsson MI, Coursin DB, Head DE, Springman SR, Wang S, Chen G, Li Q, Krueger DC, Binkley N, Sigurdsson GH, Hogan KJ.

Acta Anaesthesiol Scand. 2014 Aug;58(7):802-6. doi: 10.1111/aas.12316. Epub 2014 Apr 3.

PMID:
25040952
38.

The feasibility and educational value of Hear My Voice, a chaplain-led spiritual life review process for patients with brain cancers and progressive neurologic conditions.

Piderman KM, Breitkopf CR, Jenkins SM, Lovejoy LA, Dulohery YM, Marek DV, Durland HL, Head DL, Swanson SW, Hogg JT, Evans JL, Jorgenson SE, Bunkowski LJ, Jones KL, Euerle TT, Kwete GM, Miller KA, Morris JR, Yoder TJ, Lapid MI, Jatoi A.

J Cancer Educ. 2015 Jun;30(2):209-12. doi: 10.1007/s13187-014-0686-y.

PMID:
24952300
39.

PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.

Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED.

Haematologica. 2014 Sep;99(9):e148-51. doi: 10.3324/haematol.2014.105452. Epub 2014 Jun 20. No abstract available.

40.

High-frequency affine mechanics and nonaffine relaxation in a model cytoskeleton.

Head DA, Ikebe E, Nakamasu A, Zhang P, Villaruz LG, Kinoshita S, Ando S, Mizuno D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Apr;89(4):042711. Epub 2014 Apr 21.

41.

Nonequilibrium structure and dynamics in a microscopic model of thin-film active gels.

Head DA, Briels WJ, Gompper G.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Mar;89(3):032705. Epub 2014 Mar 10.

42.

Prefrontal gray matter volume mediates age effects on memory strategies.

Kirchhoff BA, Gordon BA, Head D.

Neuroimage. 2014 Apr 15;90:326-34. doi: 10.1016/j.neuroimage.2013.12.052. Epub 2013 Dec 31.

43.

Languages of Grief: a model for understanding the expressions of the bereaved.

Corless IB, Limbo R, Bousso RS, Wrenn RL, Head D, Lickiss N, Wass H.

Health Psychol Behav Med. 2014 Jan 1;2(1):132-143. Epub 2014 Jan 22.

44.

Linear surface roughness growth and flow smoothening in a three-dimensional biofilm model.

Head DA.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Sep;88(3):032702. Epub 2013 Sep 3.

45.

Local mechanical response in semiflexible polymer networks subjected to an axisymmetric prestress.

Head DA, Mizuno D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Aug;88(2):022717. Epub 2013 Aug 28.

46.

An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.

Jarman ER, Khambata VS, Cope C, Jones P, Roger J, Ye LY, Duggan N, Head D, Pearce A, Press NJ, Bellenie B, Sohal B, Jarai G.

Am J Respir Cell Mol Biol. 2014 Jan;50(1):158-69. doi: 10.1165/rcmb.2013-0174OC.

PMID:
23977848
47.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, O'Donnell MR, Shami PJ, Stein BL, Stone RM, Thompson JE, Westervelt P, Wheeler B, Shead DA, Naganuma M.

J Natl Compr Canc Netw. 2013 Jul;11(7):838-74.

48.

Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus.

Gordon BA, Blazey T, Benzinger TL, Head D.

J Alzheimers Dis. 2013;37(1):41-50. doi: 10.3233/JAD-130011.

49.

Physical activity and cognitive trajectories in cognitively normal adults: the adult children study.

Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):50-7. doi: 10.1097/WAD.0b013e31829628d4.

50.

Medial temporal lobe volume predicts elders' everyday memory.

Bailey HR, Zacks JM, Hambrick DZ, Zacks RT, Head D, Kurby CA, Sargent JQ.

Psychol Sci. 2013 Jul 1;24(7):1113-22. doi: 10.1177/0956797612466676. Epub 2013 Apr 29.

Supplemental Content

Support Center